ISHIDA Tatsuhiro

J-GLOBAL         Last updated: Oct 25, 2019 at 14:02
 
Avatar
Name
ISHIDA Tatsuhiro
E-mail
ishidatokushima-u.ac.jp
Affiliation
The University of Tokushima
Section
Institute of Health Biosciences The University of Tokushima Graduate School
Job title
Associate Professor
Degree
(BLANK)(The University of Tokushima)

Research Areas

 
 

Academic & Professional Experience

 
1998
 - 
2000
post-doctoral fellow,University of Alberta,
 
 
   
 
Canada
 

Education

 
 
 - 
1998
Graduate School, Division of Pharmaceutical Sciences, The University of Tokushima
 
 
 - 
1993
Faculty of Pharmaceutical Science, The University of Tokushima
 

Awards & Honors

 
Jun 2006
The APSTJ Global Education Seminar Presentation Award 2006
 
Apr 2000
Travel Award for attending to Millennial World Congress of Pharmaceutical Sciences
 
Jun 1999
The Nagai Foundation Tokyo, Graduate Student Award
 
Jun 1997
The Nagai Foundation Tokyo, Graduate Student Award
 
Apr 1997
The Nagai Foundation Tokyo, Graduate Student Award
 

Published Papers

 
Mohamed M, Abu Lila AS, Shimizu T, Alaaeldin E, Hussein A, Sarhan HA, Szebeni J, Ishida T
Science and technology of advanced materials   20(1) 710-724   Dec 2019   [Refereed]
Cancer cell-type tropism is one of crucial determinants for the efficient systemic delivery of cancer cell-derived exosomes to tumor tissues
Emam Emam Abdallah Sherif, Lila Selim Ahmed Ali Abu Amr, Elhewan Emam Elsadek Emam Ali Nehal, Hidenori Andou, Taro Shimizu, Keiichiro Okuhira, Yu Ishima, M Mahdy, E Ghazy, Tatsuhiro Ishida
European Journal of Pharmaceutics and Biopharmaceutics   Vol.145 27-34   Dec 2019   [Refereed]
Ando H, Fukushima M, Eshima K, Hasui T, Shimizu T, Ishima Y, Huang CL, Wada H, Ishida T
Cancer medicine      Oct 2019   [Refereed]
田島健次, 小瀬亮太, 松島得雄, 石田竜弘, 安藤英紀
日本醸造協会誌   114(9) 540‐549   Sep 2019
Mori Hiroyo, Kawai Nobuhiko, Kinouchi Nao, Hichijo Natsuko, Ishida Tatsuhiro, Kawakami Emi, Noji Sumihare, Tanaka Eiji
DEVELOPMENT GROWTH & DIFFERENTIATION   61(6) 389   Aug 2019   [Refereed]
Koba R, Fujita H, Nishibori M, Saeki K, Nagayoshi K, Sadakari Y, Nagai S, Sekizawa O, Nitta K, Manabe T, Ueki T, Ishida T, Oda Y, Nakamura M
International journal of cancer      Jul 2019   [Refereed]
Oxaliplatin (l-OHP), a platinum-based drug, is a key chemotherapeutic agent for colorectal cancer (CRC), but drug resistance and toxic effects have been major limitations of its use. Synchrotron radiation X-ray fluorescence spectrometry (SR-XRF) i...
Ichimizu S, Watanabe H, Maeda H, Hamasaki K, Ikegami K, Chuang VTG, Kinoshita R, Nishida K, Shimizu T, Ishima Y, Ishida T, Seki T, Katsuki H, Futaki S, Otagiri M, Maruyama T
Journal of controlled release : official journal of the Controlled Release Society   304 156-163   Jun 2019   [Refereed]
We recently developed a cell-penetrating drug carrier composed of albumin (HSA) combined with palmitoyl-cyclic-(D-Arg). While it is possible that the palmitoyl-cyclic-(D-Arg)/HSA enters the cell mainly via macropinocytosis, the mechanism responsib...
Doi Y, Shimizu T, Ishima Y, Ishida T
International journal of pharmaceutics   564 237-243   Jun 2019   [Refereed]
Liposomal anticancer drugs have been developed with improved clinical effects and reduced side effects. We have developed a PEGylated liposomal formulation of oxaliplatin that has anticancer effects in animal models of colorectal cancer with a fav...
Ando H, Abu Lila AS, Fukushima M, Matsuoka R, Shimizu T, Okuhira K, Ishima Y, Huang CL, Wada H, Ishida T
International journal of pharmaceutics   564 256-262   Jun 2019   [Refereed]
RNA interference (RNAi) is one of the most promising strategies for cancer therapeutics. The successful translation of RNAi therapeutics to a clinic setting requires a delivery system that is efficient and simple to upscale. In this study, we devi...
Kawahara H, Miyashita N, Tachibana K, Tsuda Y, Morimoto K, Tsuji K, Shigenaga A, Otaka A, Ishida T, Okuhira K
Biological & pharmaceutical bulletin   42(6) 1019-1024   Jun 2019   [Refereed]
Apolipoprotein A-I (apoA-I) plays a critical role in high-density lipoprotein (HDL) biogenesis, function and structural dynamics. Peptides that mimic apoA-I have a short amphipathic α-helical structure that can functionally recapitulate many of th...

Books etc

 
セルロースナノファイバー製造・利用の最新動向(宇山 浩 監修)
田島 健次, 小瀬 亮太, Tatsuhiro Ishida, 松島 得雄 (Part:Joint Work, 第1編 製造と評価 第6章 発酵ナノセルロースの大量生産とその応用)
Nankodo   Feb 2019   ISBN:978-4-7813-1404-4
Immune response to PEGylated nanomedicines: Impact of IgM Response
Lila Selim Ahmed Ali Abu Amr, Tatsuhiro Ishida
The Springer International Publishing AG   Jun 2018   
PEGylation and anti-PEG antibodies.
Lila Selim Ahmed Ali Abu Amr, Taro Shimizu, Tatsuhiro Ishida
Pan Stanford Publishing   Jan 2018   
Accelerated blood clearance phenomenon and complement activation-related pseudoallergy: two sides of the same coin
Lila Selim Ahmed Ali Abu Amr, J Szebeni., Tatsuhiro Ishida
Pan Stanford Publishing   2018   
Anti-PEG immunity against PEGylated therapeutics.
Lila Selim Ahmed Ali Abu Amr, Tatsuhiro Ishida
Pan Stanford Publishing   2018   
The accelerated blood clearance (ABC) phenomenon of PEGylated nanocarriers.
Lila Selim Ahmed Ali Abu Amr, Tatsuhiro Ishida
Pan Stanford Publishing   2018   
ドラッグデリバリーシステム(DDS,薬物送達システム)
Tatsuhiro Ishida
Nankodo   Mar 2017   
ドラッグデリバリーシステム(DDS)
Tatsuhiro Ishida, Hidenori Andou
京都廣川書店   2015   
Liposomal nanomedicine
Lila Selim Ahmed Ali Abu Amr, Tatsuhiro Ishida, T Allen
World Scientific   Oct 2014   
腫瘍内微小環境の能動的制御に基づくDDSの開発とがん治療への応用
Tatsuhiro Ishida, Hiroshi Kiwada
CMC Publishing Co.,Ltd.   Jun 2013   

Conference Activities & Talks

 
リポソームを用いたDDSの開発研究 [Invited]
Tatsuhiro Ishida
日本油化学会第58回年会   24 Sep 2019   
天然物による膜トランスポーターABCA7の発現増強機構の解析
Kohshi Kusumoto, 堂前 純子, Naonobu Tanaka, Yoshiki Kashiwada, Daisuke Tsuji, Kouji Itou, Tatsuhiro Ishida, Keiichiro Okuhira
第92回日本生化学会大会   19 Sep 2019   
A novel antigen delivery system: Antigen-selective delivery to splenic marginal zone B cells via repeated injections of PEGylated liposomes [Invited]
Tatsuhiro Ishida, Taro Shimizu
Liposome Research Days 2019   18 Sep 2019   
PEG-G-CSF immunogenicity in mice: Anti-PEG IgM induction
Nehal Ali Emam Elsadek Emam Elhewan, Taro Shimizu, Tatsuhiro Ishida
Liposome Research Days 2019   16 Sep 2019   
The impact of cell-type tropism on the intratumor accumulation of exosomes derived from cancer cells
Sherif Abdallah Emam Emam, Hidenori Andou, Taro Shimizu, Tatsuhiro Ishida
Liposome Research Days 2019   16 Sep 2019   
Macrophages contribute to anti-PEG IgM production and the subsequent accelerated blood clearance of PEGylated liposomes
M Mohamed, Taro Shimizu, Tatsuhiro Ishida
Liposome Research Days 2019   16 Sep 2019   
Combination of cancer vaccines with liposomal oxaliplatin increased anti-cancer therapeutic efficacy by stimulating antitumor immunity
Taro Shimizu, Shunsuke Takese, Yu Ishima, Tatsuhiro Ishida
Liposome Research Days 2019   16 Sep 2019   
Enhanced therapeutic efficacy of liposomal weak-base anticancer drugs by daily oral administration of sodium bicarbonate
Maho Tagami, Hidenori Andou, Ai Ikeda, K Eshima, C.L Huang, H Wada, Tatsuhiro Ishida
Liposome Research Days 2019   16 Sep 2019   
Gene therapy with lipoplexes may worsen inflammation via formation of immune complexes with pre-existing anti-DNA antibodies in SLE-prone mice
Haruka Takata, Taro Shimizu, Tatsuhiro Ishida
Liposome Research Days 2019   16 Sep 2019   
Immunization method to obtain antigen-specific antibodies by antigen delivery to splenic marginal zone B cells using PEGylated liposomes
Yuna Shimazaki, Hidenori Andou, Taro Shimizu, Yu Ishima, Tatsuhiro Ishida
Liposome Research Days 2019   16 Sep 2019   

Research Grants & Projects

 
Grants-in-Aid for Scientific Research
Project Year: Oct 2019 - Mar 2022    Investigator(s): ISHIDA Tatsuhiro
Grants-in-Aid for Scientific Research
Project Year: Apr 2019 - Mar 2022    Investigator(s): 田島 健次
Grants-in-Aid for Scientific Research
Project Year: Apr 2018 - Mar 2021    Investigator(s): 異島 優
Grants-in-Aid for Scientific Research
Project Year: Jun 2018 - Mar 2020    Investigator(s): 石田 竜弘
Grants-in-Aid for Scientific Research
Project Year: Apr 2016 - Mar 2019    Investigator(s): 石田 竜弘
Drug Delivery Technology to Increase the Water Solubility of Gambogic Acid and its Interaction with Activated Macrophages
Project Year: Apr 2018 - Mar 2019    Investigator(s): ISHIDA Tatsuhiro
Grants-in-Aid for Scientific Research
Project Year: Apr 2016 - Mar 2018    Investigator(s): 石田 竜弘
Grants-in-Aid for Scientific Research
Project Year: Apr 2015 - Mar 2018    Investigator(s): 南川 典昭
Grants-in-Aid for Scientific Research
Project Year: Apr 2015 - Mar 2018    Investigator(s): 石田 竜弘
Grants-in-Aid for Scientific Research
Project Year: Apr 2014 - Mar 2016    Investigator(s): ISHIDA Tatsuhiro